Cervical Dysplasia Clinical Trials

A listing of Cervical Dysplasia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 98 clinical trials
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group, Dose-Ranging Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease

This study will evaluate the efficacy and safety of CIN-107 for the treatment of hypertension in patients with uncontrolled hypertension and Chronic Kidney Disease (CKD).

nephropathy
  • 0 views
  • 18 Sep, 2022
  • 19 locations
Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy

The proposed randomized control trial will evaluate auricular point acupressure (APA) on chemotherapy-induced neuropathy (CIN), rigorously considering point specificity and placebo effects by

Accepts healthy volunteers
  • 0 views
  • 12 Nov, 2021
  • 1 location
Papilocare : Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and Tolerance

clinical trial comparing the regression rate after 12 months of histologically confirmed cervical intraepithelial lesions 1 in 2 parallel groups. One group using the vaginal gel Papilocare for 6 months and one group without any treatment.

low-grade squamous intraepithelial lesion
colposcopy
hpv vaccine
smear
human papillomavirus
  • 4 views
  • 18 Nov, 2021
  • 1 location
  • 7 views
  • 17 Sep, 2022
  • 15 locations
Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. (Vulvar-AIN)

Almost half of all women will develop an HPV infection in their lifetime. While most infections are naturally asymptomatic or cleared by the immune system, some persist and can lead to the development of cervical, vulvar, or anal lesions and eventually cancer. Screening regimens for these lesions are currently only …

cancer
dysplasia
vulvar dysplasia
smear
anal pap smear
  • 0 views
  • 01 Mar, 2022
  • 1 location
Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions

Phase II clinical trial, monocentric, not controlled, in patients with high grade cervical intraepithelial lesions. A total of 62 patients with a diagnosis of CIN II, III or carcinoma in situ

ocoxin-viusid
blood cell count
human papillomavirus
cone biopsy
colposcopy
  • 19 views
  • 24 Jul, 2022
  • 1 location
A Phase I/II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers

Background Human papillomavirus (HPV) can cause cervical, throat, anal, and genital cancers. Cancers caused by HPV have a HPV protein called E7 inside of their cells. In this new therapy, researchers take a person s blood, remove certain white blood cells, and insert genes that make them to target cancer …

aldesleukin
cancer
chemotherapy drugs
absolute neutrophil count
chemotherapy regimen
  • 370 views
  • 16 Sep, 2022
  • 1 location
Effectiveness of Remote Ischemic Preconditioning for Prevention of Contrast Induced Acute Kidney Injury in Patients Undergoing Coronary Angiograms. (RIP-CI-AKI)

The use of imaging is increasing in clinical practice, either for diagnosis or intervention. In these imaging processes, contrast medium (CM) is widely used. However, CM administration can induce contrast-induced nephropathy (CI-AKI). CI-AKI is the third most common cause of renal insufficiency, and its incidence varies from 2% to 50% …

  • 0 views
  • 02 May, 2022
  • 1 location
Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma

Prospective, multicenter, single-arm, open label, interventional study evaluating adoptive cell therapy (ACT) with autologous tumor infiltrating lymphocytes (TIL) infusion (LN-145) followed by IL-2 after a non-myeloablative (NMA) lymphodepletion preparative regimen for the treatment of patients with recurrent, metastatic, or persistent cervical carcinoma

cancer
pembrolizumab
cervical carcinoma
chemoradiotherapy
immunomodulator
  • 1113 views
  • 28 Jan, 2022
  • 20 locations
Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer

This clinical trial studies the feasibility of using hypo-fractionated radiotherapy for the treatment of cervical or endometrial cancer. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects.

cancer
adenocarcinoma
hysterectomy
tumor cells
  • 0 views
  • 07 Jan, 2022
  • 1 location